// App-Quantinova.ai

TCT-601 : Real-world experience of the polymer-free rapamycin-eluting YUKON-Choice stent: five-year results from a prospective registry

Researchers

Presenter

  • Marc-Alexander Ohlow

Principal Investigators

  • Hubertus von Korn

  • Ahmed Farah

  • Jorg Fuhrmann

  • Yu Jiangtao

  • Oliver Gunkel

  • Matthias Schreiber

  • Bernward Lauer

Medical Centers

  • Zentralklinik Bad Berka, Bad Berka, Germany

  • Klinikum, Frankfurt/Oder, Germany

  • Hetzelstift, Neustadt, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Hypercholesterolemia, Familial, 1

  • Renal insufficiency

  • Hypertension

  • Venous thrombosis

  • Restenosis

  • Coronary Artery Disease

  • Diabetes

  • Angina

Biomarkers

  • Acetyl-CoA carboxylase

  • Insulin

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved